Clinical Trial: Fanconi Syndrome Due to ARVs in HIV-Infected Persons
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: A Preliminary Evaluation of Fanconi Syndrome Due to Antiretroviral Therapies in HIV-Infected Persons
Brief Summary: Cross-sectional cohort study of participants with HIV with or without protocol-defined Fanconi syndrome (confirmed creatinine clearance [CLcr] decline and evidence of proximal tubulopathy).
Detailed Summary:
Sponsor: Gilead Sciences
Current Primary Outcome:
- Time to TDF discontinuation after diagnosis of Fanconi syndrome [ Time Frame: Up to 48 weeks ]
- Time to confirmed resolution of Fanconi syndrome [ Time Frame: Up to 48 weeks ]
Original Primary Outcome: This study is descriptive in nature and does not evaluate safety and efficacy of treatment.
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Gilead Sciences
Dates:
Date Received: July 9, 2007
Date Started: September 2007
Date Completion:
Last Updated: March 14, 2014
Last Verified: March 2014
